March 1, 2021
Business News

AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

MASON, Ohio–()–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced fourth quarter 2020 and full year 2020 financial results.

“Despite challenges posed in 2020 as a result of the pandemic, we made meaningful progress across our business with our strategic initiatives,” said Michael Carrel, President and Chief Executive Officer of AtriCure. “Looking ahead to 2021 and beyond, we are building on the strength of our core platform with key catalysts on the horizon which expand our market opportunities and position the company well for accelerated and sustainable revenue growth over the long term.”


Click here to view the original article.

Related Posts

You might also like ...

Granite Receives 68 Diamond Commendations From NAPA
Equity Commonwealth Announces $150 Million Share Repurchase Authorization
Thompson Hospitality Founder and CEO to Get Spotlight at Fairfax County EDA’s March 2 Entrepreneurship Workshop